(Date:10/10/2008)...ng point for behavior change, DES MOINES, Iowa, O...,Americans (51 percent) believe there are good thi...r changes are needed, according to the 2008,EBRI H...oday by the,Employee Benefit Research Institute an...derwritten by the Principal Financial Group(R)., ...
(Date:10/10/2008)...dentialing Center (ANCC) has designated Geisinger ...s came via a conference call to hospital administr...and applause., GMC joins an elite group of only 1...n the United States that have achieved Magnet stat...s recognition., "Achieving Magnet designation is ...
(Date:10/10/2008)... blame , , FRIDAY, Oct. 10 (HealthDay Ne...ve diabetes, being depressed was associated with a..., Publishing in the October issue of the Journal...he University of Washington tracked 10,704 Medicar...d diabetes and were enrolled in a disease manageme...
(Date:10/10/2008)...llence in the implementation of electronic health ...agement Systems Society (HIMSS) announces the reci...onal, Ambulatory and Community Health Organization...L (PRWEB) October 10, 2008 -- Honoring excellence ... (EHRs), the Healthcare Information and Managemen...
Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5... because it robs individuals of their bone strengt...ndition that causes bones to thin, weaken and brea...l people over the age of 75. One in eight men over...ture of some kind in his lifetime. Fractures due t...
...eat! Experts have now learned that other factors b...hey may be diet and vitamin-related. A nutrition-..., C, E and folic acid, is detrimental to skin. One...n is also one of the most common: C.// As one of t...
...ers female hormone levels and may thereby reduce b... thousands of years - the fibres to make linen and...e rich in lignans, which resemble the female hormo...gen are linked to breast cancer and lignans may lo...
...nic in Rochester, Minnesota Vitamin E is one of th...lashes. Estrogen relieves hot flashes in most wom...cer survivors because the hormone may stimulate br... cohosh seems to alleviate hot flashes and other s...
Other Medicine News:(Date:10/10/2008)...10 /- Boston Scientific,Cor...e of the Company,s major,events and press announce...(CRF) twentieth annual Transcatheter Cardiovascula...uns from October 12 to 17 in Washington, D.C., Bo... safety and,efficacy data on its TAXUS(R) Express2...
(Date:10/9/2008)...ncreased Sales and Marketing Efforts to Accelerate...ystem, MENLO PARK, Calif., Oct. 9 /-...vices for the percutaneous repair of cardiac valve...team with the appointment of,Sean Cleary as senior...nd,Chris Richardson, as vice president of sales., ...
(Date:10/8/2008).... 8 /PRNewswire-USNewswire/ -- The facts are,overw...IV/AIDS in,sub-Saharan Africa. More than 35,000,00...ave already died of AIDS. The Foundation for Hospi... dying and their families,find compassion and reli...vative partnering initiative links African hospice...
(Date:10/8/2008)...ram to be Discontinued and Headcount to be Reduced...tfolio Review; Zanolimumab Program to be Disconti... Employees, COPENHAGEN,...MX: GEN),announced today that it is discontinuing ...tion, as a result of a portfolio review and,assess...
Breaking Medicine Technology:Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6Evalve Expands Executive Leadership Team 2Evalve Expands Executive Leadership Team 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 2In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 4Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 3Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 4Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay 196 1Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay 196 2Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay 196 3Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay 196 4PRA International Adds Dr Susan Stansfield as Executive Vice President 529 1PRA International Adds Dr Susan Stansfield as Executive Vice President 529 2PRA International Adds Dr Susan Stansfield as Executive Vice President 529 3AKELA Pharma Inc announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN 28R 29 trial 526 1AKELA Pharma Inc announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN 28R 29 trial 526 2AKELA Pharma Inc announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN 28R 29 trial 526 3Vical to Present at Upcoming Investor Conferences 367 1Vical to Present at Upcoming Investor Conferences 367 2...7, 2007 - BioLineRx Ltd.,(TASE:BLRX), Israel,s lea...clinical data from trials of BL-1040 demonstrating...tion of the myocardium,after a myocardial infarcti...n and eventual heart failure in a pig model. Profe...rdiac Research,Institute at Sheba Medical Center i...
...rial data underlines M6G,s,benefit compared to mor...MBRIDGE, England, 7th March 2007 - CeNeS Pharmaceu...maceutical company today,announces additional data...(morphine-6-glucuronide) in over 500 patients with...d on 20th February,showed that M6G provided equiva...
Other Medicine Technology:BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality 2BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality 3CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 2CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 3CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 4CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 5CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 6CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 7Cold light source triple outlet.
Cold light source dual outlet.
Cold light source dual outlet.
The 4150S is a state of the art 150 Watt halogen light source with an integrated intensity control and a standard coupler to connect optical fiber light guides. This light source distinguishes itself
Medicine Products: